Qsab 013
Qsab 013
Qsab 013
doi: 10.1093/jaoacint/qsab013
Advance Access Publication Date: 30 January 2021
Article
NATURAL PRODUCTS
Abstract
Background: The roots of Argyreia speciosa (Linn. F) Sweet (family: Convolvulaceae) are used in Ayurveda to treat male
reproductive and nervous system disorders.
Objective: Isolation of scopoletin from the roots of Argyreia speciosa, and development and validation of an analytical method
using HPLC for the quantification of scopoletin from the root powder of Argyreia speciosa.
Method: Scopoletin was isolated from chloroform fraction prepared from hydrolyzed methanolic extract and identified using
spectral studies. A reverse-phase HPLC-based analytical method was developed and optimized using the Design of Experiment
(DoE) approach to estimate scopoletin from the roots of Argyreia speciosa. Scopoletin was separated and quantified using HPLC
containing the C18 column and a PDA detector. The optimized mobile phase was methanol: water (pH3.2) [25: 75, %v/v].
Results: The Box–Behnken design was used to optimize chromatographic parameters and the extraction procedure. The
validation studies showed a linear relationship (r2¼0.998) in the range of 1–40 mg/mL. The LOD and LOQ were found to be
0.28 mg/mL and 0.84 mg/mL, respectively, and the recovery values were found to be between 91.94 and 97.86%. The developed
analytical method was found to be robust as well. The amount of scopoletin was estimated to be 0.024 6 0.0016%w/w from
dried root powder.
Conclusion: The recorded chromatogram and amount of scopoletin determined would serve as one of the standardization
parameters to access the quality of raw material containing Argyreia speciosa.
Highlights: Developed analytical method may be adopted as a part of the standardization procedure for Argyreia speciosa in
the quality control laboratory.
Argyreia speciosa (Linn. F) Sweet (family: Convolvulaceae) (A. spe- debilities, nervous system diseases, chronic ulcers, etc. (1).
ciosa) is indicated in Ayurveda and found all over India. It is tra- Studies have shown that methanol extract from different
ditionally used in the treatment of male reproductive function parts of A. speciosa has antibacterial, anti-cancer, anti-diarrheal,
1167
1168 | Patel et al.: Journal of AOAC INTERNATIONAL Vol. 104, No. 4, 2021
content was cooled at room temperature and partitioned with Estimation of Scopoletin from Methanolic Extract of
100 mL chloroform using a 500 mL capacity separating funnel. A. speciosa
This procedure was repeated five times. The content was
shaken vigorously for 10 min and kept aside for phase (a) Optimizing chromatographic conditions for the HPLC method
Few pre-experiments were carried out with the help of the sam-
separation. The chloroform layers were collected and mixed.
ple solution (chloroform fraction (accurately weighed about
The collected chloroform was passed through anhydrous so-
20 mg) diluted using methanol (10 mL)) to resolve the peak cor-
dium sulfate and evaporated to dryness using a rotary vacuum
responding to scopoletin using HPLC. The optimization of chro-
evaporator at 40 C (30).
matographic parameters was carried out by adopting the Box–
Behnken design (31). Percentage of methanol (% v/v) in mobile
Column Chromatographic Separation phase (A ¼ 20%, 25%, and 30%), pH of mobile phase (B ¼ 3.0, 3.2,
and 3.4), temperature (C ¼ 27, 30, and 33 C), and flow rate (FR)
Scopoletin was separated from chloroform enriched fraction
(D ¼ 1.0, 1.2, and 1.4 mL/min) were selected as independent vari-
using column chromatography. The silica gel (150 g) for column
ables to be optimized. The selection of the variable was based
solution was injected in HPLC and chromatogram was recorded showed a single spot. Figure 2 suggested the absence of constit-
by following optimized chromatographic conditions. The uents other than the isolated constituent. These fractions were
chromatogram recorded after injecting the standard solution of finally mixed and evaporated to dryness which yielded 27 mg of
scopoletin (40 mg/mL) and the sample solution (10 mg/mL chlo- the isolated constituent.
roform fraction) is presented for comparison. Peak correspond-
ing to scopoletin was integrated and the area covered by the Spectroscopic Studies
peak was recorded. The amount of scopoletin was calculated by
inserting the peak area in a line equation to get the concentra- Wavenumber corresponding to various stretches from recorded
tion of scopoletin in the injected sample solution, which will IR spectra of the isolated compound, as shown in Figure 3, and
further yield the amount of scopoletin present in dried plant those were from reported IR spectra of scopoletin are summa-
material. Five independent experiments were performed and rized in Table 1. The stretch corresponding to the hydroxyl
the mean value for the percentage of scopoletin present on a group in recorded spectra was not sharp as well as appeared at
dried weight basis of plant material was reported. wavenumber lesser than reported for a hydroxyl group. It sug-
gests that the hydroxyl groups might be hydrogen-bonded in
the constituent. Stretch appeared at 3025 cm1 as well, as over-
-1 a -1 a
1 3480 cm OH 3336.80 cm OH
2 – – 3025,3010cm-1 a Cyclic vinyl C-H
3 – – 2945, 2850 cm-1 a Methyl C-H
4 1715 cm-1 a C¼O 1704 cm-1 a C¼O
5 1610 cm-1 a C¼C 1608.05 cm-1 a C¼C
6 1540 cm-1 a , 1403 cm-1 a Aromatic 1511.36, 1432.54 cm-1 b Aromatic
7 – – 1219 cm-1 b C(alk) – O–C(ary) (assy)
8 – – 1018 cm-1 b C(alk) – O–C(ary) (sym)
a
s ¼ small
b
m ¼ medium
The methanolic extract was subjected to acid hydrolysis to get as the basis of the selection of independent variables for DoE,
sample solution containing total scopoletin. which might constitute 34 full factorial design having 81 experi-
The HPLC method was developed using a trial-and-error ap- mental runs. As Box–Behnken design yielded a fewer number of
proach to yield well resolved, sharp, and Gaussian peak corre- experiments, it was selected to evolve design space, which
sponding to scopoletin, from a solution prepared from yielded 29 runs, as shown in Table 3, along with the value of the
hydrolyzed fraction. Initial trials suggested that the methanol– selected dependent variable for each run. As shown in Table 4,
water mixture yielded better peak shape as compared to the when two-way ANOVA was applied to determine the level of
acetonitrile–water mixture, furthermore the temperature of the significance for the model, yielded p-value less than 0.05 sug-
column oven affected the peak shape. The wavelength was se- gested that the model was significant statistically and, the pre-
lected based on the UV spectrum of the peak and the mobile dicted R2 value for most of the factors was in reasonable
phase having a pH of more than four could not resolve the peak agreement of adjusted R2 value. Signal to noise ratio was repre-
of scopoletin from nearby peaks. These observations remained sented by determining Adeq precision and the value of Adeq
Patel et al.: Journal of AOAC INTERNATIONAL Vol. 104, No. 4, 2021 | 1173
Values derived from reported 1H- NMR spectra of scopoletin [30] Values derived from reported 1H- NMR spectra
Sr. No. d, ppm Integration and assignment d, ppm Integration and assignment
a
s ¼ singlet
b
d ¼ doublet
precision was more than four in all the cases suggested that the the column oven. The perturbation graph, as shown in
model could be used to navigate design space. Predicted Figure 6A suggested that amongst the selected factors, FR (D)
Residual Error Sum of Squares Statistics (PRESS) is the measure had a notable impact on the area of the peak. It was also ob-
of the discrepancy between the data and an estimated model, served that except pH, all selected variables had a significant ef-
thus, PRESS is used to cross-validate the regression analysis. fect on RT. The perturbation chart shown in Figure 6B suggested
The optimal PRESS value for the dependent variables suggested that the amount of methanol in the mobile phase had maxi-
the appropriate selection of the model. The analysis of the mum impact on RT among all the selected factors. Initial obser-
responses suggested that the model was significant (P < 0.005) vations suggested that the temperature of the column oven
for the responses (31). The detailed statistical analysis sug- affected the shape and TF of the peak. The perturbation graph,
gested that the area corresponding to the scopoletin peak was as shown in Figure 6C, suggested that methanol proportion in
not affected significantly by incorporating alteration in the the mobile phase, the temperature of the column oven, and FR
amount of methanol in the mobile phase, pH, or temperature of affected the TF significantly. Plant extract and fractions form a
1174 | Patel et al.: Journal of AOAC INTERNATIONAL Vol. 104, No. 4, 2021
Sr. No Dependent variable P-value for model R2 Adjusted R2 Adeq. precision PRESS Suggested model
complex matrix while considering for chemical analysis. The to peak corresponding to scopoletin. The statistical analysis
sample solution showed a positive reaction for flavonoids and revealed that all selected factors, except the FR, affected the res-
phenolics, which might be attributed to the presence of phenyl olution of the peak, which is seen in the perturbation chart
propanoids. The fraction also contained alkaloids and steroids, shown in Figure 6D. The contour plot, as shown in Figure 7A,
including other terpenoids (35). Resolving scopoletin in the shows the effect of the proportion of methanol in the mobile
presence of other secondary metabolites was a challenging task phase and pH on the resolution of the peak corresponding to
and the most demanding feature of the proposed analytical scopoletin, when temperature and FR was kept constant. The
method. The range of the independent variables was selected to plot suggested that obtaining the value of resolution of the peak
have minimal effect on peak shape and resolution. The studies corresponding to scopoletin more than 2.0, the proportion of
showed that all selected independent variables had an impact methanol in the mobile phase would be more than 22% v/v, and
on the resolving ability of the analytical method with reference the pH of the mobile phase should be more than 3.0. The results
1176 | Patel et al.: Journal of AOAC INTERNATIONAL Vol. 104, No. 4, 2021
obtained were subjected to graphical optimization. The value of using a laboratory bath sonicator. The FR was set at 1.2 mL/min,
independent variables was inserted and with the help of the with an injection volume of 20 mL. The chromatogram was
Design Expert an overlay graph was constructed, as shown in recorded at 345 nm, and the temperature of column oven was
Figure 7B. The overlay graph shows the area of possible re- set at 30˚C.
sponse values in the factor space. The level of significance was Statistical analysis of the results of the experiments, per-
selected as 0.05. The golden yellow region in Figure 7B shows formed to optimize the experimental variables involved in the
that the range of all intervals meets the specified criteria of sta- sample solution preparation, suggested that the model selected
tistical significance. Three random points were flagged from the for optimizing the variable was statistically significant
yellow area of the overlay graph, which yielded the value of in- (P ¼ 0.004). The variables had a statistically significant effect on
dependent variables as well as the determined value of depen- the selected response. The difference between adjusted R2 and
dent variables (P< 0.05). The chromatogram was recorded using predicted R2 was 0.4, with a good precision value of 8.89. PRESS
the same variables and the average value of responses were was determined to be 0.0001. The results of the statistical analy-
obtained. The deviation in each response was measured be- sis suggested that the adopted model was adequate, and design
tween the determined value and practically achieved value, as space could be navigated from the model. The perturbation
Figure 7. Counter view and overlay plot for optimization of chromatographic parameters.
Table 5. Assessing the fitness of the suggested model in optimizing chromatographic conditions
Value of independent variable Difference between predicted and experimentally obtained value for dependent variables, %
(n ¼ 3) temperature ¼30 C, flow rate ¼ 1.2 mL/min, using sample solution (2.0 mg/mL)
Patel et al.: Journal of AOAC INTERNATIONAL Vol. 104, No. 4, 2021 | 1177
1 50 70 3 0.024
2 50 90 5 0.018
3 10 70 3 0.012
4 30 70 5 0.023
5 50 50 5 0.02
6 30 50 3 0.018
7 30 70 5 0.024
8 30 70 5 0.023
9 10 50 5 0.017
10 30 90 3 0.02
11 30 70 5 0.019
12 50 70 7 0.018
a
(n ¼ 3)
Figure 8. Counter view and overlay plot for optimizing the variable for preparing the sample solution from the plant material.
for 30 min at 60 C. The overlay graph, as shown in Figure 8B was The chromatogram which was recorded using the optimized
generated from the data set, considering the significance level chromatographic conditions for standard scopoletin and the
0.05, suggested heating the content for more than 25 min at a sample solution are shown in Figure 9A and B, respectively.
temperature of more than 60 C, would yield the maximum These figures show the Gaussian and well-resolved peak corre-
amount of scopoletin. The model was validated by performing sponding to scopoletin.
experiments by selecting the variables from the design space,
as shown in Table 7. The results ensured the validation of the
Analytical Method Validation
model for the purpose. The experimental conditions, including
heating of 0.1 g methanolic extract in 20 mL, 5% v/v hydrochloric The results of the system suitability parameters, as shown in
acid for 30 min at 70˚C was selected as optimized conditions, Table 8, would be of importance while implementing the
based on graphical determination and practical method at different laboratories. The selectivity of the analyti-
experimentations. cal method is the ability to measure an analyte accurately in the
1178 | Patel et al.: Journal of AOAC INTERNATIONAL Vol. 104, No. 4, 2021
Table 7. Assessing fitness of the suggested model for optimizing sample solution preparation process
Table 8. System suitability parametersa presence of interference (32). The peak purity for the peak corre-
sponding to Scopoletin was measured using a PDA detector be-
Sr. No. Parameters Mean area 6 SD %, RSD tween 380 nm and 220 nm at all points of a peak. The peak
purity index was 0.995 when determined using software for
1 Number of plates 4896.4 6 60.71 1.24
peak corresponding to scopoletin after injecting sample solu-
2 Peak area 279582.5 6 986.50 0.35
3 Resolution 3.78 6 0.0175 0.45
tion indicated the spectral purity of the peak.
4 Tailing factor 1.09 6 0.0051 0.47 Summary of the results of validation studies, as shown in
Table 9, suggested that linearity was established from the value
a
(n ¼ 6) using sample solution (2.20 mg/mL) of the regression coefficient of a calibration curve. The calibra-
tion curve was established by plotting the graph of peak area vs.
Patel et al.: Journal of AOAC INTERNATIONAL Vol. 104, No. 4, 2021 | 1179
1 Selectivity through peak purity analysis Peak purity more than 0.950
2 Linearity (1.02–40.8 mg/mL) Slope (m) 47924.33 6 141.41
y-intercept 7886.48 6 116.30
Regression coefficient (r2) 0.998 6 0.0008
Intraday precision (%, RSD) 0.26–0.54
Interday precision (%, RSD) 0.40–1.50
4 Sensitivity LOD 0.28 mg/mL
LOQ 0.84 mg/mL
5 Accuracy through Standard Addition Method (% recovery) 91.94–97.86%
6 Robustness (F-Test) Fexp < Fcrit, null hypothesis accepted Robust
4. Subramoniam, A., Madhavachandran, V., Ravi, K., & Anuja, 21. Li, Z., Wang, L., Yang, G., Shi, H., Jiang, C., Liu, W., & Zhang, Y.
V.S. (2007) J. Endocrinol. Reprod. 11, 82–85 (2003) J. Chromatogr. Sci. 41, 36–40
5. Vyas, N., Gamit, K., Raval, M., & Patel, S. (2019) Asian J. Pharm. 22. Sethiya, N.K., Trivedi, A., & Mishra, S.H. (2015) Rev. Bras.
Clin. Res. 12, 276–280 Farmacogn. 25, 193–198
6. Habbu, P.V., Mahadevan, K.M., Kulkarni, P.V., Daulatsingh, 23. Waksmundzka-Hajnos, M., Petruczynik, A., Hajnos, M.L.,
C., Veerapur, V.P., & Shastry, R.A. (2010) Indian J. Exp. Biol. 48, Tuzimski, T., Hawryl, A., & Bogucka-Kocka, A. (2006) J.
53–60 Chromatogr. Sci. 44, 510–517
7. Habbu, P.V., Mahadevan, K.M., Shastry, R.A., & Manjunatha, 24. Dixit, V., & Nahata, A. (2008) Indian J. Pharm. Sci. 70, 834–837
H. (2009) Indian J. Exp. Biol. 47, 121–128 25. Chen, J., Chen, L., Zhang, H.-L., & Shi, Y.-P. (2010) J. AOAC Int.
8. Nair, G., Daniel, M., & Sabnis, S. (1987) Indian J. Pharm. Sci. 49, 93, 1410–1415
100–102 26. Vyas, N., Raval, M., & Patel, N. (2020) Sep. Sci. Plus. 3, 362–368
9. Rani, A., & Shukla, Y. (1997) Indian J. Chem. 36, 299–300 27. Kashyap, P., Ram, H., Shukla, S.D., & Kumar, S. (2020) J. Exp.
10. Shrivastava, A., & Shukla, Y. (1998) Indian J. Chem. 37, 192–194 Neurosci. 15, 263310552093769
11. Ali, S., Hamed, M.A., El-Rigal, N.S., Shabana, M.H., & Kassem, 28. Vogt, F.G., & Kord, A.S. (2011) J. Pharm. Sci. 100, 797–812